Preclinical studies of PF-04849285, an interferon-α8 fusion protein for the treatment of HCVVICTORIA FLORES, M; HICKLING, Timothy P; COREY, Thomas et al.Antiviral therapy (London). 2012, Vol 17, Num 5, pp 869-881, issn 1359-6535, 13 p.Article

Reduced maximal inhibition in phenotypic susceptibility assays indicates that viral strains resistant to the CCR5 antagonist maraviroc utilize inhibitor-bound receptor for entryWESTBY, Mike; SMITH-BURCHNELL, Caroline; MORI, Julie et al.Journal of virology. 2007, Vol 81, Num 5, pp 2359-2371, issn 0022-538X, 13 p.Article